Cengild Medical Berhad Cash Flow Conversion Efficiency

Latest as of June 2026: 0.039x

Cengild Medical Berhad cash flow conversion efficiency. Based on the latest financial reports, Cengild Medical Berhad (0243) has a cash flow conversion efficiency ratio of 0.039x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM4.65 Million ≈ $1.17 Million USD) by net assets (RM120.02 Million ≈ $30.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Cengild Medical Berhad (2020–2026)

Cash flow conversion efficiency of Cengild Medical Berhad from 2020 to 2026. This chart illustrates how Cengild Medical Berhad's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 0243 live share price for real-time trading data and today's change.

Cengild Medical Berhad Cash Flow Conversion Ratio Explained

Cengild Medical Berhad cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Cengild Medical Berhad Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cengild Medical Berhad ranked by their cash flow conversion efficiency. Also see 0243 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ai-Media Technologies Ltd AU:AIM	0.037x
Atlantaa Limited NSE:ATLANTAA	-0.073x
Kishin Corporation KO:092440	0.004x
Wellbiotec Co. Ltd. KO:010600	-0.033x
Tracxn Technologies Limited NSE:TRACXN	0.019x
Adveritas Ltd AU:AV1	5.266x
Willowglen MSC Bhd KLSE:0008	-0.147x
Kartal Yenilenebilir Enerji Uretim AS IS:KARYE	-0.059x

Annual Cash Flow Conversion Efficiency for Cengild Medical Berhad (2020–2026)

The table below shows the annual cash flow conversion efficiency of Cengild Medical Berhad from 2020 to 2026. Review 0243 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	RM120.02 Million ≈ $30.13 Million	RM13.10 Million ≈ $3.29 Million	0.109x	-22.28%
2025-06-30	RM114.46 Million ≈ $28.74 Million	RM16.08 Million ≈ $4.04 Million	0.140x	+20.87%
2024-06-30	RM111.30 Million ≈ $27.94 Million	RM12.94 Million ≈ $3.25 Million	0.116x	-10.39%
2023-06-30	RM106.11 Million ≈ $26.64 Million	RM13.76 Million ≈ $3.46 Million	0.130x	-14.22%
2022-06-30	RM92.95 Million ≈ $23.34 Million	RM14.05 Million ≈ $3.53 Million	0.151x	-85.43%
2021-06-30	RM13.78 Million ≈ $3.46 Million	RM14.30 Million ≈ $3.59 Million	1.038x	-9.62%
2020-06-30	RM9.79 Million ≈ $2.46 Million	RM11.24 Million ≈ $2.82 Million	1.148x	--

About Cengild Medical Berhad

KLSE:0243 Malaysia Medical Care Facilities

Market Cap

$33.46 Million

RM133.27 Million MYR

Market Cap Rank

#23194 Global

#557 in Malaysia

Share Price

RM0.16

Change (1 day)

+0.00%

52-Week Range

RM0.16 - RM0.24

All Time High

RM0.55